Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared to other strains on the rise, but it does have a greater ability to bind to human cells, suggesting it could be more transmissible.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

A class of drugs known as Janus kinase, or JAK, inhibitors, which work by slowing down the immune system, should be the first-line therapy for patients hospitalized for COVID-19, researchers reported in The Lancet Respiratory Medicine.

Theatre nurse David Collyer wanted to shoot a documentary photography project in the last years of the Welsh hospital he worked in. Then Covid-19 appeared.

The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.

Plus, new clues about the rise in colorectal cancer rates in young adults. You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday.